1. Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement. Issue 4 (4th August 2015) Authors: Tsitoura, D; Ambery, C; Price, M; Powley, W; Garthside, S; Biggadike, K; Quint, D Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 4(2015:Oct.) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗